Cargando…

Differential marker expression by cultures rich in mesenchymal stem cells

BACKGROUND: Mesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires standardized techniques for their specific isolation. To date, there are no conclusive marker (s) for the exclusive isolation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wetzig, Andrew, Alaiya, Ayodele, Al-Alwan, Monther, Pradez, Christian Benedict, Pulicat, Manogaran S, Al-Mazrou, Amer, Shinwari, Zakia, Sleiman, Ghida Majed, Ghebeh, Hazem, Al-Humaidan, Hind, Gaafar, Ameera, Kanaan, Imaduddin, Adra, Chaker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235221/ https://www.ncbi.nlm.nih.gov/pubmed/24304471 http://dx.doi.org/10.1186/1471-2121-14-54

Ejemplares similares

Profiling of normal and malignant breast tissue show CD44(high)/CD24(low) phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
por: Ghebeh, Hazem, et al.
Publicado: (2013)

Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
por: Ghebeh, Hazem, et al.
Publicado: (2010)

Anti-Inflammatory Effect of Specialized Proresolving Lipid Mediators on Mesenchymal Stem Cells: An In Vitro Study
por: AlZahrani, Shahd, et al.
Publicado: (2022)

Proteomic Profiling of the First Human Dental Pulp Mesenchymal Stem/Stromal Cells from Carbonic Anhydrase II Deficiency Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2020)

Carbonic Anhydrase II Activators in Osteopetrosis Treatment: A Review
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Fluconazole-Induced Protein Changes in Osteogenic and Immune Metabolic Pathways of Dental Pulp Mesenchymal Stem Cells of Osteopetrosis Patients
por: Alkhayal, Zikra, et al.
Publicado: (2023)

Fascin Activates β-Catenin Signaling and Promotes Breast Cancer Stem Cell Function Mainly Through Focal Adhesion Kinase (FAK): Relation With Disease Progression
por: Barnawi, Rayanah, et al.
Publicado: (2020)

Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
por: Al-Alwan, Monther, et al.
Publicado: (2011)

PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
por: Mansour, Fatmah A., et al.
Publicado: (2020)

PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
por: Almozyan, Sheema, et al.
Publicado: (2017)

WT1 peptide analogue WT1-126Y enhances leukemia lysis
por: Alqudaihi, Ghofran, et al.
Publicado: (2014)

The selective cytotoxic anti-cancer properties and proteomic analysis of Trigonella Foenum-Graecum
por: Alsemari, Abdulaziz, et al.
Publicado: (2014)

A study of KIR genes and HLA-C in Vogt-Koyanagi-Harada disease in Saudi Arabia
por: Sheereen, Atia, et al.
Publicado: (2011)

Bidirectional crosstalk between PD-L1 expression and epithelial to mesenchymal transition: Significance in claudin-low breast cancer cells
por: Alsuliman, Abdullah, et al.
Publicado: (2015)

Sex-Biased Expression of Genes Allocated in the Autosomal Chromosomes: Blood LC-MS/MS Protein Profiling in Healthy Subjects
por: Giha, Hayder A., et al.
Publicado: (2023)

β1 Integrin is essential for fascin‐mediated breast cancer stem cell function and disease progression
por: Barnawi, Rayanah, et al.
Publicado: (2019)

Integrated Left Ventricular Global Transcriptome and Proteome Profiling in Human End-Stage Dilated Cardiomyopathy
por: Colak, Dilek, et al.
Publicado: (2016)

Comprehensive Transcriptome and Pathway Analyses Revealed Central Role for Fascin in Promoting Triple-Negative Breast Cancer Progression
por: Barnawi, Rayanah, et al.
Publicado: (2021)

LC-MS/MS proteomic analysis revealed novel associations of 37 proteins with T2DM and notable upregulation of immunoglobulins
por: Abdulwahab, Rabab Asghar, et al.
Publicado: (2019)

Higher PD-L1 Immunohistochemical Detection Signal in Frozen Compared to Matched Paraffin-Embedded Formalin-Fixed Tissues
por: Ghebeh, Hazem, et al.
Publicado: (2021)

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females
por: Al-Moghrabi, Nisreen, et al.
Publicado: (2014)

Proteomic Analysis of Morphologically Changed Tissues after Prolonged Dexamethasone Treatment
por: Malkawi, Abeer K., et al.
Publicado: (2019)

Inhibition of signaling downstream of beta‐2 adrenoceptor by propranolol in prostate cancer cells
por: Alaskar, Aljoharah, et al.
Publicado: (2022)

Proteomics Profiling to Distinguish DOCK8 Deficiency From Atopic Dermatitis
por: Jacob, Minnie, et al.
Publicado: (2021)

Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya, Ayodele, et al.
Publicado: (2021)

Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1
por: Islam, Syed S., et al.
Publicado: (2019)

Curcumin induces re-expression of BRCA1 and suppression of γ synuclein by modulating DNA promoter methylation in breast cancer cell lines
por: Al-Yousef, Nujoud, et al.
Publicado: (2020)

ZNFX1 Deficiency in a Child with Interstitial Pneumonitis and Peripheral Monocytosis
por: Al-Saud, Bandar, et al.
Publicado: (2023)

Comprehensive multi-omics analysis of G6PC3 deficiency-related congenital neutropenia with inflammatory bowel disease
por: Dasouki, Majed, et al.
Publicado: (2021)

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
por: Al Sayed, Adher D., et al.
Publicado: (2019)

Prognostic markers compared to CD3+TIL in locally advanced nasopharyngeal carcinoma
por: Al-Rajhi, Nasser, et al.
Publicado: (2021)

Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway
por: Ghebeh, H, et al.
Publicado: (2014)

AUF1 promotes stemness in human mammary epithelial cells through stabilization of the EMT transcription factors TWIST1 and SNAIL1
por: AlAhmari, Manar M., et al.
Publicado: (2020)

HMOX1 is partly responsible for phenotypic and functional abnormalities in mesenchymal stem cells/stromal cells from placenta of preeclampsia (PE) patients
por: Basmaeil, Yasser S., et al.
Publicado: (2020)

Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients
por: Alaiya, Ayodele A., et al.
Publicado: (2016)

FOXP3(+ )T(regs )and B7-H1(+)/PD-1(+ )T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy
por: Ghebeh, Hazem, et al.
Publicado: (2008)

HLA-DRB1 among patients with Vogt-Koyanagi-Harada disease in Saudi Arabia
por: Iqniebi, Alia, et al.
Publicado: (2009)

Differential expression of CCR2 and CX(3)CR1 on CD16(+) monocyte subsets is associated with asthma severity
por: Al-Rashoudi, Reem, et al.
Publicado: (2019)

Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy
por: Al-Dhfyan, Abdullah, et al.
Publicado: (2022)

Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer
por: Ghebeh, Hazem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tf1t429r025nnm960kotio5a5s